You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 289 No. 24, June 25, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Immunization
 •Alert me on articles by topic

Smallpox Immunization in the 21st Century

The Old and the New

Mary E. Wright, MD MPH; Anthony S. Fauci, MD

JAMA. 2003;289:3306-3308.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Just over 6 months ago a decision was made to reinstitute smallpox vaccination for selected segments of the US population.1 This decision to implement a pre-event smallpox vaccination program was based on the concern that smallpox could be used as an agent of bioterrorism; however, certain questions about the risk of smallpox vaccination in a 21st-century setting arose.2-3 Among these was the possibility that the current United States population might be more vulnerable to serious adverse effects of the smallpox vaccine due to a relative increase—compared with 3 to 4 decades ago—in conditions affecting the immune system such as the use of immunosuppressive drugs and the presence of human immunodeficiency virus infection in the community. A consequence of this change in population profile could be an increased incidence of established adverse events as well as the emergence of heretofore unrecognized adverse . . . [Full Text of this Article]

Author Affiliations: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services.


RELATED ARTICLES

US Military Smallpox Vaccination Program Experience
John D. Grabenstein and William Winkenwerder, Jr
JAMA. 2003;289(24):3278-3282.
ABSTRACT | FULL TEXT  

Myopericarditis Following Smallpox Vaccination Among Vaccinia-Naive US Military Personnel
Jeffrey S. Halsell, James R. Riddle, J. Edwin Atwood, Pierce Gardner, Robert Shope, Gregory A. Poland, Gregory C. Gray, Stephen Ostroff, Robert E. Eckart, Duane R. Hospenthal, Roger L. Gibson, John D. Grabenstein, Mark K. Arness, and David N. Tornberg
JAMA. 2003;289(24):3283-3289.
ABSTRACT | FULL TEXT  

Focal and Generalized Folliculitis Following Smallpox Vaccination Among Vaccinia-Naive Recipients
Thomas R. Talbot, H. Keipp Bredenberg, Michael Smith, Bonnie J. LaFleur, Alan Boyd, and Kathryn M. Edwards
JAMA. 2003;289(24):3290-3294.
ABSTRACT | FULL TEXT  

Response to Smallpox Vaccine in Persons Immunized in the Distant Past
Sharon E. Frey, Frances K. Newman, Lihan Yan, and Robert B. Belshe
JAMA. 2003;289(24):3295-3299.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Smallpox Vaccine Safety
JWatch Infect. Diseases 2003;2003:1-1.
FULL TEXT  

Some Answers to Smallpox Vaccination Questions
JWatch General 2003;2003:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.